Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
BACKGROUND:Multiple Sclerosis (MS) is a chronic inflammatory, immune mediated disease of the central nervous system, with Relapsing Remitting MS (RRMS) being the most common type. Within the last years, the status of high disease activity (HDA) has become increasingly important for clinical decision...
Main Authors: | Christoph Ohlmeier, Holger Gothe, Judith Haas, Ulrike Osowski, Carina Weinhold, Sarah Blauwitz, Niklas Schmedt, Wolfgang Galetzka, Fabian Berkemeier, Björn Tackenberg, Martin Stangel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231846 |
Similar Items
-
Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data
by: Christoph Ohlmeier, et al.
Published: (2019-12-01) -
Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE)
by: Ralf Gold, et al.
Published: (2018-04-01) -
A case of relapsing and remitting ptosis
by: Radhakrishna Hari, et al.
Published: (2019-01-01) -
Natalizumab for relapsing-remitting multiple sclerosis
by: A. Horga, et al.
Published: (2011-01-01) -
Natalizumab for relapsing remitting multiple sclerosis
by: Pucci, Eugenio, et al.
Published: (2011)